Jason is the head of corporate affairs at Frequency Therapeutics, which includes communications, investor relations, patient advocacy and policy. He has more than two decades of experience in corporate communications and public affairs, most recently as head of corporate communications at Moderna. Prior to that, he headed corporate communications at Biogen, where he led media relations, executive and internal communications, corporate branding and corporate citizenship programs.

Jason also spent nearly a decade at the global communications firm Fleishman-Hillard, where he was a senior vice president and senior partner, including six years as general manager of its Boston office. He started his career as a journalist. He holds a M.S. in Journalism from Boston University and a B.A. in English Literature from Washington University in St. Louis.